April 04, 2026 03:31 pm (IST)
Follow us:
Pfizer stops sale of Corex cough syrup in India after ban
Mumbai, Mar 14 (IBNS) Pharmaceutical major Pfizer has stopped manufacture and sale of popular cough syrup Corex with immediate effect after a ban by the Government.
“This is to inform you that the Government of India has prohibited the manufacture for sale, sale and distribution of fixed dose combination of Chlopheniramine Maleate + Codeine Syrup with immediate effect,” Pfizer said in a BSE filing on Monday.
“In view of this, the company has discontinued the manufacture and sale of its drug Corex with immediate effect," it said.
Pfizer said it believed Corex had a "well-established efficacy and safety profile in India for more than 30 years," adding that the company was "exploring all possible options at its disposal."
Pfizer said the prohibition on Corex is likely to have an adverse impact on the revenue and profitability of the company.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Is sitting the new danger? Experts issue heart warning
Wed, Apr 01 2026
Abdominal or central obesity is a greater risk factor compared to overall obesity: Indian Minister
Sun, Mar 29 2026
Big move in healthcare! IIT Kharagpur, Charnock Hospital unite for advance research, clinical excellence
Fri, Mar 27 2026
Dying with dignity: India’s slow, uneasy acceptance of euthanasia
Wed, Mar 25 2026